Outcome prediction following radical nephroureterectomy for upper tract urothelial carcinoma
•This predictive model was based on 239 patients with 41 months of mean follow up.•Assessed cancer specific, overall and metastasis free survival.•The c-index was 0.71 for OS, 0.72 for MFS and 0.74 for CSS.•Externally validated accuracy: 78.4%, 71.4%, and 75.3% for OS, CSS, and MFS, respectively. To...
Gespeichert in:
Veröffentlicht in: | Urologic oncology 2021-02, Vol.39 (2), p.133.e9-133.e16 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 133.e16 |
---|---|
container_issue | 2 |
container_start_page | 133.e9 |
container_title | Urologic oncology |
container_volume | 39 |
creator | Abdul-Muhsin, Haidar De Lucia, Noel Singh, Vijay Faraj, Kassem Rose, Kyle Cha, Stephen Zhang, Nan Judge, Nathanael Navaratnam, Anojan Tyson, Mark Ho, Thai Jacobsohn, Kenneth Castle, Erik |
description | •This predictive model was based on 239 patients with 41 months of mean follow up.•Assessed cancer specific, overall and metastasis free survival.•The c-index was 0.71 for OS, 0.72 for MFS and 0.74 for CSS.•Externally validated accuracy: 78.4%, 71.4%, and 75.3% for OS, CSS, and MFS, respectively.
To predict overall survival, cancer, and metastasis specific survival in upper tract urothelial carcinoma (UTUC) following radical nephroureterectomy (RNU).
All nonmetastatic UTUC patients who underwent RNU with a curative intent at 1 institution between December 1998 and January 2017 were included. Detailed data were collected. End points for this study included OS, CCS, and MFS. Univariate and multivariate analysis were conducted. Log Rank tests and Kaplan-Meier curves were generated. Backward elimination and boot strapping was used to identify the most parsimonious model with the smallest number of variables in order to predict the outcomes of interest. A separate second institution data base was used for external validation.
There were 218 patients in the development cohort. Mean follow-up was 42 months (±39.6). There was 99 (45.4%) deaths, 28 (12.8%) cancer related deaths, 72 (33%) recurrences, and 54 (24.8%) metastases. The c-index for our model was 0.71 for OS, 0.72 for MFS and 0.74 for CSS. The nomograms did not show significant deviation from actual observations using our calibration plots. We divided the patient into 3 different groups (low, intermediate and high risk) based on their final total score for each outcome and compared them. On external validation our accuracy was 78.4%, 71.4%, and 75.3% for OS, CSS, and MFS survival respectively.
We designed a predictive model for survival outcomes following RNU in UTUC. This model uses simple, readily available data for patients without the need for expensive or additional testing. |
doi_str_mv | 10.1016/j.urolonc.2020.08.021 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2452100117</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1078143920303859</els_id><sourcerecordid>2452100117</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-44e026961af32c71f7831489d1e657bad60a033f6b3443560685347db2ba62243</originalsourceid><addsrcrecordid>eNqFkEtLxDAQgIMoPlZ_gtKjl9a8255ExBcseNGbENJ06mZpm5qkiv_eLLt69TTD8M3rQ-ic4IJgIq_Wxexd70ZTUExxgasCU7KHjklVspzyWu6nHJdVTjirj9BJCGuMCa8IOURHjGFZCyGO0dvzHI0bIJs8tNZE68asc33vvuz4nnmdarrPRphW3s0eIngw0Q3fCfLZPE3gs-i1iVm6Jq6gt4k22hs7ukGfooNO9wHOdnGBXu_vXm4f8-Xzw9PtzTI3TIqYcw6YyloS3TFqStKVFUuX1i0BKcpGtxJrzFgnG8Y5ExLLSjBetg1ttKSUswW63M6dvPuYIUQ12GCg7_UIbg6KckFJ-p6UCRVb1HgXgodOTd4O2n8rgtVGrFqrnVi1EatwpZLY1HexWzE3A7R_Xb8mE3C9BSA9-mnBq2AsjCZZ3ShTrbP_rPgBxtmNWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2452100117</pqid></control><display><type>article</type><title>Outcome prediction following radical nephroureterectomy for upper tract urothelial carcinoma</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Abdul-Muhsin, Haidar ; De Lucia, Noel ; Singh, Vijay ; Faraj, Kassem ; Rose, Kyle ; Cha, Stephen ; Zhang, Nan ; Judge, Nathanael ; Navaratnam, Anojan ; Tyson, Mark ; Ho, Thai ; Jacobsohn, Kenneth ; Castle, Erik</creator><creatorcontrib>Abdul-Muhsin, Haidar ; De Lucia, Noel ; Singh, Vijay ; Faraj, Kassem ; Rose, Kyle ; Cha, Stephen ; Zhang, Nan ; Judge, Nathanael ; Navaratnam, Anojan ; Tyson, Mark ; Ho, Thai ; Jacobsohn, Kenneth ; Castle, Erik</creatorcontrib><description>•This predictive model was based on 239 patients with 41 months of mean follow up.•Assessed cancer specific, overall and metastasis free survival.•The c-index was 0.71 for OS, 0.72 for MFS and 0.74 for CSS.•Externally validated accuracy: 78.4%, 71.4%, and 75.3% for OS, CSS, and MFS, respectively.
To predict overall survival, cancer, and metastasis specific survival in upper tract urothelial carcinoma (UTUC) following radical nephroureterectomy (RNU).
All nonmetastatic UTUC patients who underwent RNU with a curative intent at 1 institution between December 1998 and January 2017 were included. Detailed data were collected. End points for this study included OS, CCS, and MFS. Univariate and multivariate analysis were conducted. Log Rank tests and Kaplan-Meier curves were generated. Backward elimination and boot strapping was used to identify the most parsimonious model with the smallest number of variables in order to predict the outcomes of interest. A separate second institution data base was used for external validation.
There were 218 patients in the development cohort. Mean follow-up was 42 months (±39.6). There was 99 (45.4%) deaths, 28 (12.8%) cancer related deaths, 72 (33%) recurrences, and 54 (24.8%) metastases. The c-index for our model was 0.71 for OS, 0.72 for MFS and 0.74 for CSS. The nomograms did not show significant deviation from actual observations using our calibration plots. We divided the patient into 3 different groups (low, intermediate and high risk) based on their final total score for each outcome and compared them. On external validation our accuracy was 78.4%, 71.4%, and 75.3% for OS, CSS, and MFS survival respectively.
We designed a predictive model for survival outcomes following RNU in UTUC. This model uses simple, readily available data for patients without the need for expensive or additional testing.</description><identifier>ISSN: 1078-1439</identifier><identifier>EISSN: 1873-2496</identifier><identifier>DOI: 10.1016/j.urolonc.2020.08.021</identifier><identifier>PMID: 33069555</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Nomogram ; Survival ; Transitional cell carcinoma ; Upper tract urothelial carcinoma ; Urothelial carcinoma</subject><ispartof>Urologic oncology, 2021-02, Vol.39 (2), p.133.e9-133.e16</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-44e026961af32c71f7831489d1e657bad60a033f6b3443560685347db2ba62243</citedby><cites>FETCH-LOGICAL-c365t-44e026961af32c71f7831489d1e657bad60a033f6b3443560685347db2ba62243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.urolonc.2020.08.021$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33069555$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abdul-Muhsin, Haidar</creatorcontrib><creatorcontrib>De Lucia, Noel</creatorcontrib><creatorcontrib>Singh, Vijay</creatorcontrib><creatorcontrib>Faraj, Kassem</creatorcontrib><creatorcontrib>Rose, Kyle</creatorcontrib><creatorcontrib>Cha, Stephen</creatorcontrib><creatorcontrib>Zhang, Nan</creatorcontrib><creatorcontrib>Judge, Nathanael</creatorcontrib><creatorcontrib>Navaratnam, Anojan</creatorcontrib><creatorcontrib>Tyson, Mark</creatorcontrib><creatorcontrib>Ho, Thai</creatorcontrib><creatorcontrib>Jacobsohn, Kenneth</creatorcontrib><creatorcontrib>Castle, Erik</creatorcontrib><title>Outcome prediction following radical nephroureterectomy for upper tract urothelial carcinoma</title><title>Urologic oncology</title><addtitle>Urol Oncol</addtitle><description>•This predictive model was based on 239 patients with 41 months of mean follow up.•Assessed cancer specific, overall and metastasis free survival.•The c-index was 0.71 for OS, 0.72 for MFS and 0.74 for CSS.•Externally validated accuracy: 78.4%, 71.4%, and 75.3% for OS, CSS, and MFS, respectively.
To predict overall survival, cancer, and metastasis specific survival in upper tract urothelial carcinoma (UTUC) following radical nephroureterectomy (RNU).
All nonmetastatic UTUC patients who underwent RNU with a curative intent at 1 institution between December 1998 and January 2017 were included. Detailed data were collected. End points for this study included OS, CCS, and MFS. Univariate and multivariate analysis were conducted. Log Rank tests and Kaplan-Meier curves were generated. Backward elimination and boot strapping was used to identify the most parsimonious model with the smallest number of variables in order to predict the outcomes of interest. A separate second institution data base was used for external validation.
There were 218 patients in the development cohort. Mean follow-up was 42 months (±39.6). There was 99 (45.4%) deaths, 28 (12.8%) cancer related deaths, 72 (33%) recurrences, and 54 (24.8%) metastases. The c-index for our model was 0.71 for OS, 0.72 for MFS and 0.74 for CSS. The nomograms did not show significant deviation from actual observations using our calibration plots. We divided the patient into 3 different groups (low, intermediate and high risk) based on their final total score for each outcome and compared them. On external validation our accuracy was 78.4%, 71.4%, and 75.3% for OS, CSS, and MFS survival respectively.
We designed a predictive model for survival outcomes following RNU in UTUC. This model uses simple, readily available data for patients without the need for expensive or additional testing.</description><subject>Nomogram</subject><subject>Survival</subject><subject>Transitional cell carcinoma</subject><subject>Upper tract urothelial carcinoma</subject><subject>Urothelial carcinoma</subject><issn>1078-1439</issn><issn>1873-2496</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkEtLxDAQgIMoPlZ_gtKjl9a8255ExBcseNGbENJ06mZpm5qkiv_eLLt69TTD8M3rQ-ic4IJgIq_Wxexd70ZTUExxgasCU7KHjklVspzyWu6nHJdVTjirj9BJCGuMCa8IOURHjGFZCyGO0dvzHI0bIJs8tNZE68asc33vvuz4nnmdarrPRphW3s0eIngw0Q3fCfLZPE3gs-i1iVm6Jq6gt4k22hs7ukGfooNO9wHOdnGBXu_vXm4f8-Xzw9PtzTI3TIqYcw6YyloS3TFqStKVFUuX1i0BKcpGtxJrzFgnG8Y5ExLLSjBetg1ttKSUswW63M6dvPuYIUQ12GCg7_UIbg6KckFJ-p6UCRVb1HgXgodOTd4O2n8rgtVGrFqrnVi1EatwpZLY1HexWzE3A7R_Xb8mE3C9BSA9-mnBq2AsjCZZ3ShTrbP_rPgBxtmNWw</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Abdul-Muhsin, Haidar</creator><creator>De Lucia, Noel</creator><creator>Singh, Vijay</creator><creator>Faraj, Kassem</creator><creator>Rose, Kyle</creator><creator>Cha, Stephen</creator><creator>Zhang, Nan</creator><creator>Judge, Nathanael</creator><creator>Navaratnam, Anojan</creator><creator>Tyson, Mark</creator><creator>Ho, Thai</creator><creator>Jacobsohn, Kenneth</creator><creator>Castle, Erik</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202102</creationdate><title>Outcome prediction following radical nephroureterectomy for upper tract urothelial carcinoma</title><author>Abdul-Muhsin, Haidar ; De Lucia, Noel ; Singh, Vijay ; Faraj, Kassem ; Rose, Kyle ; Cha, Stephen ; Zhang, Nan ; Judge, Nathanael ; Navaratnam, Anojan ; Tyson, Mark ; Ho, Thai ; Jacobsohn, Kenneth ; Castle, Erik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-44e026961af32c71f7831489d1e657bad60a033f6b3443560685347db2ba62243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Nomogram</topic><topic>Survival</topic><topic>Transitional cell carcinoma</topic><topic>Upper tract urothelial carcinoma</topic><topic>Urothelial carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abdul-Muhsin, Haidar</creatorcontrib><creatorcontrib>De Lucia, Noel</creatorcontrib><creatorcontrib>Singh, Vijay</creatorcontrib><creatorcontrib>Faraj, Kassem</creatorcontrib><creatorcontrib>Rose, Kyle</creatorcontrib><creatorcontrib>Cha, Stephen</creatorcontrib><creatorcontrib>Zhang, Nan</creatorcontrib><creatorcontrib>Judge, Nathanael</creatorcontrib><creatorcontrib>Navaratnam, Anojan</creatorcontrib><creatorcontrib>Tyson, Mark</creatorcontrib><creatorcontrib>Ho, Thai</creatorcontrib><creatorcontrib>Jacobsohn, Kenneth</creatorcontrib><creatorcontrib>Castle, Erik</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdul-Muhsin, Haidar</au><au>De Lucia, Noel</au><au>Singh, Vijay</au><au>Faraj, Kassem</au><au>Rose, Kyle</au><au>Cha, Stephen</au><au>Zhang, Nan</au><au>Judge, Nathanael</au><au>Navaratnam, Anojan</au><au>Tyson, Mark</au><au>Ho, Thai</au><au>Jacobsohn, Kenneth</au><au>Castle, Erik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcome prediction following radical nephroureterectomy for upper tract urothelial carcinoma</atitle><jtitle>Urologic oncology</jtitle><addtitle>Urol Oncol</addtitle><date>2021-02</date><risdate>2021</risdate><volume>39</volume><issue>2</issue><spage>133.e9</spage><epage>133.e16</epage><pages>133.e9-133.e16</pages><issn>1078-1439</issn><eissn>1873-2496</eissn><abstract>•This predictive model was based on 239 patients with 41 months of mean follow up.•Assessed cancer specific, overall and metastasis free survival.•The c-index was 0.71 for OS, 0.72 for MFS and 0.74 for CSS.•Externally validated accuracy: 78.4%, 71.4%, and 75.3% for OS, CSS, and MFS, respectively.
To predict overall survival, cancer, and metastasis specific survival in upper tract urothelial carcinoma (UTUC) following radical nephroureterectomy (RNU).
All nonmetastatic UTUC patients who underwent RNU with a curative intent at 1 institution between December 1998 and January 2017 were included. Detailed data were collected. End points for this study included OS, CCS, and MFS. Univariate and multivariate analysis were conducted. Log Rank tests and Kaplan-Meier curves were generated. Backward elimination and boot strapping was used to identify the most parsimonious model with the smallest number of variables in order to predict the outcomes of interest. A separate second institution data base was used for external validation.
There were 218 patients in the development cohort. Mean follow-up was 42 months (±39.6). There was 99 (45.4%) deaths, 28 (12.8%) cancer related deaths, 72 (33%) recurrences, and 54 (24.8%) metastases. The c-index for our model was 0.71 for OS, 0.72 for MFS and 0.74 for CSS. The nomograms did not show significant deviation from actual observations using our calibration plots. We divided the patient into 3 different groups (low, intermediate and high risk) based on their final total score for each outcome and compared them. On external validation our accuracy was 78.4%, 71.4%, and 75.3% for OS, CSS, and MFS survival respectively.
We designed a predictive model for survival outcomes following RNU in UTUC. This model uses simple, readily available data for patients without the need for expensive or additional testing.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33069555</pmid><doi>10.1016/j.urolonc.2020.08.021</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1078-1439 |
ispartof | Urologic oncology, 2021-02, Vol.39 (2), p.133.e9-133.e16 |
issn | 1078-1439 1873-2496 |
language | eng |
recordid | cdi_proquest_miscellaneous_2452100117 |
source | Elsevier ScienceDirect Journals Complete |
subjects | Nomogram Survival Transitional cell carcinoma Upper tract urothelial carcinoma Urothelial carcinoma |
title | Outcome prediction following radical nephroureterectomy for upper tract urothelial carcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T10%3A31%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcome%20prediction%20following%20radical%20nephroureterectomy%20for%20upper%20tract%20urothelial%20carcinoma&rft.jtitle=Urologic%20oncology&rft.au=Abdul-Muhsin,%20Haidar&rft.date=2021-02&rft.volume=39&rft.issue=2&rft.spage=133.e9&rft.epage=133.e16&rft.pages=133.e9-133.e16&rft.issn=1078-1439&rft.eissn=1873-2496&rft_id=info:doi/10.1016/j.urolonc.2020.08.021&rft_dat=%3Cproquest_cross%3E2452100117%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2452100117&rft_id=info:pmid/33069555&rft_els_id=S1078143920303859&rfr_iscdi=true |